Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Satellos Bioscience Inc. (MSCLF) had Stock-Based Compensation of $1.54M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-4.34M |
|
-- |
|
-- |
|
$5.58M |
|
$-5.58M |
|
$1.24M |
|
$-4.34M |
|
$-4.36M |
|
$-4.34M |
|
$-4.34M |
|
$-4.34M |
|
$-4.36M |
|
$-5.58M |
|
$-5.59M |
|
114.78M |
|
114.78M |
|
$-0.04 |
|
$-0.04 |
|
| Balance Sheet Financials | |
$53.28M |
|
$0.00M |
|
$0.00M |
|
$53.29M |
|
$3.76M |
|
-- |
|
-- |
|
$3.76M |
|
$49.53M |
|
$49.53M |
|
$49.53M |
|
165.82M |
|
| Cash Flow Statement Financials | |
$-18.23M |
|
$4.63M |
|
$39.03M |
|
$16.10M |
|
$42.08M |
|
$25.98M |
|
|
Stock-Based Compensation |
$1.54M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.16 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-18.23M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-8.77% |
|
-8.77% |
|
-8.15% |
|
-8.77% |
|
$0.30 |
|
$-0.16 |
|
$-0.16 |
|